STOCK TITAN

[Form 4] Natera, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Natera, Inc. (NTRA) – Form 4 insider activity filed 07/03/2025

Director Gail Marcus Boxer exercised 4,299 stock-option shares at an exercise price of $24.42 on 07/01/2025 (Code M). The same day, she sold the entire 4,299 shares in two open-market blocks under a pre-arranged Rule 10b5-1 plan adopted 12/11/2024:

  • 1,648 shares at a weighted-average price of $167.0518 (range $166.2989–$167.2833)
  • 2,651 shares at a weighted-average price of $167.5554 (range $167.30–$168.0343)

Gross proceeds approximate $718 k, implying a spread of roughly $142.6 per share versus the $24.42 strike. Following the transactions, Boxer's direct ownership declines to 8,118 common shares, down from 12,417 immediately after the option exercise. No derivative securities remain outstanding from the exercised grant (expiration 09/13/2028).

The trade represents a cashless, plan-based disposition and involves a modest share count relative to Natera’s >100 million shares outstanding, suggesting limited fundamental impact on the company’s capital structure. However, investors often monitor insider net selling for sentiment cues, even when conducted under 10b5-1 plans.

Natera, Inc. (NTRA) – Attività insider Form 4 registrata il 03/07/2025

La direttrice Gail Marcus Boxer ha esercitato 4.299 azioni da opzione al prezzo di esercizio di $24,42 il 01/07/2025 (Codice M). Nello stesso giorno, ha venduto tutte le 4.299 azioni in due blocchi sul mercato aperto secondo un piano predefinito Rule 10b5-1 adottato il 11/12/2024:

  • 1.648 azioni a un prezzo medio ponderato di $167,0518 (intervallo $166,2989–$167,2833)
  • 2.651 azioni a un prezzo medio ponderato di $167,5554 (intervallo $167,30–$168,0343)

Il ricavo lordo è di circa $718.000, con uno spread di circa $142,6 per azione rispetto al prezzo di esercizio di $24,42. Dopo le transazioni, la posizione diretta di Boxer scende a 8.118 azioni ordinarie, rispetto alle 12.417 subito dopo l’esercizio dell’opzione. Non rimangono titoli derivati in circolazione dall’assegnazione esercitata (scadenza 13/09/2028).

L’operazione rappresenta una cessione senza esborso di denaro, basata su piano e coinvolge un numero di azioni modesto rispetto alle oltre 100 milioni di azioni di Natera in circolazione, suggerendo un impatto fondamentale limitato sulla struttura del capitale dell’azienda. Tuttavia, gli investitori seguono spesso la vendita netta degli insider per segnali di sentiment, anche quando effettuata sotto piani 10b5-1.

Natera, Inc. (NTRA) – Actividad de insider Formulario 4 presentada el 03/07/2025

La directora Gail Marcus Boxer ejerció 4,299 opciones sobre acciones a un precio de ejercicio de $24.42 el 01/07/2025 (Código M). Ese mismo día, vendió las 4,299 acciones completas en dos bloques en el mercado abierto bajo un plan preestablecido Regla 10b5-1 adoptado el 11/12/2024:

  • 1,648 acciones a un precio promedio ponderado de $167.0518 (rango $166.2989–$167.2833)
  • 2,651 acciones a un precio promedio ponderado de $167.5554 (rango $167.30–$168.0343)

Los ingresos brutos son aproximadamente $718,000, lo que implica un diferencial de aproximadamente $142.6 por acción respecto al precio de ejercicio de $24.42. Tras las transacciones, la propiedad directa de Boxer disminuye a 8,118 acciones comunes, desde 12,417 justo después del ejercicio de la opción. No quedan valores derivados pendientes de la concesión ejercida (vencimiento 13/09/2028).

La operación representa una disposición basada en un plan sin efectivo y abarca un número modesto de acciones en comparación con las más de 100 millones de acciones en circulación de Natera, lo que sugiere un impacto fundamental limitado en la estructura de capital de la empresa. Sin embargo, los inversores suelen monitorear la venta neta de insiders para señales de sentimiento, incluso cuando se realiza bajo planes 10b5-1.

Natera, Inc. (NTRA) – 2025년 7월 3일 제출된 Form 4 내부자 거래 내역

이사 Gail Marcus Boxer는 2025년 7월 1일 (코드 M) 4,299주 스톡옵션을 행사가격 $24.42에 행사했습니다. 같은 날, 그녀는 2024년 12월 11일 채택된 사전 계획된 Rule 10b5-1 플랜에 따라 두 개의 공개시장 블록에서 전량 4,299주를 매도했습니다:

  • 1,648주를 가중평균 가격 $167.0518에 매도 (범위 $166.2989–$167.2833)
  • 2,651주를 가중평균 가격 $167.5554에 매도 (범위 $167.30–$168.0343)

총 매출은 약 $718,000이며, 행사가격 $24.42 대비 주당 약 $142.6의 차익을 의미합니다. 거래 후 Boxer의 직접 보유 주식 수는 8,118주로 감소했으며, 옵션 행사 직후 12,417주에서 줄어들었습니다. 행사된 부여에서 파생된 증권은 남아 있지 않습니다 (만기 2028년 9월 13일).

이번 거래는 현금 유출 없는 플랜 기반 처분으로, Natera의 1억 주 이상의 발행 주식 대비 적은 수량의 주식을 포함하고 있어 회사 자본 구조에 미치는 근본적 영향은 제한적일 것으로 보입니다. 그러나 투자자들은 10b5-1 플랜 하에서 이루어지는 경우에도 내부자 순매도를 투자 심리 신호로 자주 관찰합니다.

Natera, Inc. (NTRA) – Activité d’initié Formulaire 4 déposée le 03/07/2025

La directrice Gail Marcus Boxer a exercé 4 299 options d’achat d’actions au prix d’exercice de 24,42 $ le 01/07/2025 (Code M). Le même jour, elle a vendu la totalité des 4 299 actions en deux blocs sur le marché libre selon un plan Rule 10b5-1 préétabli adopté le 11/12/2024 :

  • 1 648 actions à un prix moyen pondéré de 167,0518 $ (fourchette 166,2989 $–167,2833 $)
  • 2 651 actions à un prix moyen pondéré de 167,5554 $ (fourchette 167,30 $–168,0343 $)

Le produit brut s’élève à environ 718 000 $, ce qui implique un écart d’environ 142,6 $ par action par rapport au prix d’exercice de 24,42 $. Après ces transactions, la détention directe de Boxer diminue à 8 118 actions ordinaires, contre 12 417 juste après l’exercice des options. Aucun titre dérivé ne reste en circulation issu de la subvention exercée (expiration 13/09/2028).

Cette opération représente une cession sans apport de liquidités, basée sur un plan et concerne un nombre d’actions modeste par rapport aux plus de 100 millions d’actions en circulation de Natera, suggérant un impact fondamental limité sur la structure du capital de la société. Toutefois, les investisseurs surveillent souvent les ventes nettes des initiés pour déceler des signaux de sentiment, même lorsqu’elles sont effectuées dans le cadre de plans 10b5-1.

Natera, Inc. (NTRA) – Insider-Transaktion Form 4 eingereicht am 03.07.2025

Direktorin Gail Marcus Boxer übte am 01.07.2025 (Code M) 4.299 Aktienoptionen zum Ausübungspreis von $24,42 aus. Am selben Tag verkaufte sie die gesamten 4.299 Aktien in zwei Blöcken am offenen Markt im Rahmen eines vorab festgelegten Rule 10b5-1 Plans, der am 11.12.2024 angenommen wurde:

  • 1.648 Aktien zu einem gewichteten Durchschnittspreis von $167,0518 (Spanne $166,2989–$167,2833)
  • 2.651 Aktien zu einem gewichteten Durchschnittspreis von $167,5554 (Spanne $167,30–$168,0343)

Der Bruttoerlös beläuft sich auf ca. $718.000, was eine Differenz von etwa $142,6 pro Aktie gegenüber dem Ausübungspreis von $24,42 bedeutet. Nach den Transaktionen sinkt Boxers direkter Aktienbesitz auf 8.118 Stammaktien, von 12.417 unmittelbar nach der Optionsausübung. Es verbleiben keine derivativen Wertpapiere aus der ausgeübten Zuteilung (Verfall 13.09.2028).

Der Handel stellt eine barrierefreie, plangestützte Veräußerung dar und umfasst eine überschaubare Anzahl von Aktien im Vergleich zu Nateras über 100 Millionen ausstehenden Aktien, was auf eine begrenzte fundamentale Auswirkung auf die Kapitalstruktur des Unternehmens hindeutet. Dennoch beobachten Investoren Insider-Verkäufe oft als Stimmungsindikator, selbst wenn sie im Rahmen von 10b5-1-Plänen erfolgen.

Positive
  • Use of Rule 10b5-1 plan signals adherence to insider-trading best practices, reducing governance risk.
  • No dilution; option exercise converted previously granted shares without increasing share count.
Negative
  • Net insider share reduction from 12,417 to 8,118 may create short-term negative sentiment.
  • Approx. $718 k cash-out could be viewed as lack of longer-term conviction despite continuing holdings.

Insights

TL;DR – Small, planned insider sale; neutral fundamental impact.

The director’s exercise-and-sell transaction converts low-priced options into cash, reducing personal exposure by 4,299 shares while still retaining 8,118 shares. Sale proceeds are modest (<1 day’s average trading volume) and executed under a valid 10b5-1 plan, lessening interpretation of opportunistic timing. With no change to total shares outstanding and negligible dilution, the filing does not alter Natera’s valuation drivers (test-volume growth, reimbursement trends, cash burn). I view the event as fundamentally neutral; any trading reaction will likely be sentiment-driven and short-lived.

TL;DR – Governance-aligned sale under 10b5-1; limited red flags.

Use of a pre-scheduled 10b5-1 plan, adopted >6 months before execution, supports transparency and mitigates insider-trading risk. The director still holds >8 k shares, preserving alignment. No executive titles were involved, further reducing governance concern. Given the modest size relative to NTRA’s float, I classify the disclosure as not impactful to governance risk scoring.

Natera, Inc. (NTRA) – Attività insider Form 4 registrata il 03/07/2025

La direttrice Gail Marcus Boxer ha esercitato 4.299 azioni da opzione al prezzo di esercizio di $24,42 il 01/07/2025 (Codice M). Nello stesso giorno, ha venduto tutte le 4.299 azioni in due blocchi sul mercato aperto secondo un piano predefinito Rule 10b5-1 adottato il 11/12/2024:

  • 1.648 azioni a un prezzo medio ponderato di $167,0518 (intervallo $166,2989–$167,2833)
  • 2.651 azioni a un prezzo medio ponderato di $167,5554 (intervallo $167,30–$168,0343)

Il ricavo lordo è di circa $718.000, con uno spread di circa $142,6 per azione rispetto al prezzo di esercizio di $24,42. Dopo le transazioni, la posizione diretta di Boxer scende a 8.118 azioni ordinarie, rispetto alle 12.417 subito dopo l’esercizio dell’opzione. Non rimangono titoli derivati in circolazione dall’assegnazione esercitata (scadenza 13/09/2028).

L’operazione rappresenta una cessione senza esborso di denaro, basata su piano e coinvolge un numero di azioni modesto rispetto alle oltre 100 milioni di azioni di Natera in circolazione, suggerendo un impatto fondamentale limitato sulla struttura del capitale dell’azienda. Tuttavia, gli investitori seguono spesso la vendita netta degli insider per segnali di sentiment, anche quando effettuata sotto piani 10b5-1.

Natera, Inc. (NTRA) – Actividad de insider Formulario 4 presentada el 03/07/2025

La directora Gail Marcus Boxer ejerció 4,299 opciones sobre acciones a un precio de ejercicio de $24.42 el 01/07/2025 (Código M). Ese mismo día, vendió las 4,299 acciones completas en dos bloques en el mercado abierto bajo un plan preestablecido Regla 10b5-1 adoptado el 11/12/2024:

  • 1,648 acciones a un precio promedio ponderado de $167.0518 (rango $166.2989–$167.2833)
  • 2,651 acciones a un precio promedio ponderado de $167.5554 (rango $167.30–$168.0343)

Los ingresos brutos son aproximadamente $718,000, lo que implica un diferencial de aproximadamente $142.6 por acción respecto al precio de ejercicio de $24.42. Tras las transacciones, la propiedad directa de Boxer disminuye a 8,118 acciones comunes, desde 12,417 justo después del ejercicio de la opción. No quedan valores derivados pendientes de la concesión ejercida (vencimiento 13/09/2028).

La operación representa una disposición basada en un plan sin efectivo y abarca un número modesto de acciones en comparación con las más de 100 millones de acciones en circulación de Natera, lo que sugiere un impacto fundamental limitado en la estructura de capital de la empresa. Sin embargo, los inversores suelen monitorear la venta neta de insiders para señales de sentimiento, incluso cuando se realiza bajo planes 10b5-1.

Natera, Inc. (NTRA) – 2025년 7월 3일 제출된 Form 4 내부자 거래 내역

이사 Gail Marcus Boxer는 2025년 7월 1일 (코드 M) 4,299주 스톡옵션을 행사가격 $24.42에 행사했습니다. 같은 날, 그녀는 2024년 12월 11일 채택된 사전 계획된 Rule 10b5-1 플랜에 따라 두 개의 공개시장 블록에서 전량 4,299주를 매도했습니다:

  • 1,648주를 가중평균 가격 $167.0518에 매도 (범위 $166.2989–$167.2833)
  • 2,651주를 가중평균 가격 $167.5554에 매도 (범위 $167.30–$168.0343)

총 매출은 약 $718,000이며, 행사가격 $24.42 대비 주당 약 $142.6의 차익을 의미합니다. 거래 후 Boxer의 직접 보유 주식 수는 8,118주로 감소했으며, 옵션 행사 직후 12,417주에서 줄어들었습니다. 행사된 부여에서 파생된 증권은 남아 있지 않습니다 (만기 2028년 9월 13일).

이번 거래는 현금 유출 없는 플랜 기반 처분으로, Natera의 1억 주 이상의 발행 주식 대비 적은 수량의 주식을 포함하고 있어 회사 자본 구조에 미치는 근본적 영향은 제한적일 것으로 보입니다. 그러나 투자자들은 10b5-1 플랜 하에서 이루어지는 경우에도 내부자 순매도를 투자 심리 신호로 자주 관찰합니다.

Natera, Inc. (NTRA) – Activité d’initié Formulaire 4 déposée le 03/07/2025

La directrice Gail Marcus Boxer a exercé 4 299 options d’achat d’actions au prix d’exercice de 24,42 $ le 01/07/2025 (Code M). Le même jour, elle a vendu la totalité des 4 299 actions en deux blocs sur le marché libre selon un plan Rule 10b5-1 préétabli adopté le 11/12/2024 :

  • 1 648 actions à un prix moyen pondéré de 167,0518 $ (fourchette 166,2989 $–167,2833 $)
  • 2 651 actions à un prix moyen pondéré de 167,5554 $ (fourchette 167,30 $–168,0343 $)

Le produit brut s’élève à environ 718 000 $, ce qui implique un écart d’environ 142,6 $ par action par rapport au prix d’exercice de 24,42 $. Après ces transactions, la détention directe de Boxer diminue à 8 118 actions ordinaires, contre 12 417 juste après l’exercice des options. Aucun titre dérivé ne reste en circulation issu de la subvention exercée (expiration 13/09/2028).

Cette opération représente une cession sans apport de liquidités, basée sur un plan et concerne un nombre d’actions modeste par rapport aux plus de 100 millions d’actions en circulation de Natera, suggérant un impact fondamental limité sur la structure du capital de la société. Toutefois, les investisseurs surveillent souvent les ventes nettes des initiés pour déceler des signaux de sentiment, même lorsqu’elles sont effectuées dans le cadre de plans 10b5-1.

Natera, Inc. (NTRA) – Insider-Transaktion Form 4 eingereicht am 03.07.2025

Direktorin Gail Marcus Boxer übte am 01.07.2025 (Code M) 4.299 Aktienoptionen zum Ausübungspreis von $24,42 aus. Am selben Tag verkaufte sie die gesamten 4.299 Aktien in zwei Blöcken am offenen Markt im Rahmen eines vorab festgelegten Rule 10b5-1 Plans, der am 11.12.2024 angenommen wurde:

  • 1.648 Aktien zu einem gewichteten Durchschnittspreis von $167,0518 (Spanne $166,2989–$167,2833)
  • 2.651 Aktien zu einem gewichteten Durchschnittspreis von $167,5554 (Spanne $167,30–$168,0343)

Der Bruttoerlös beläuft sich auf ca. $718.000, was eine Differenz von etwa $142,6 pro Aktie gegenüber dem Ausübungspreis von $24,42 bedeutet. Nach den Transaktionen sinkt Boxers direkter Aktienbesitz auf 8.118 Stammaktien, von 12.417 unmittelbar nach der Optionsausübung. Es verbleiben keine derivativen Wertpapiere aus der ausgeübten Zuteilung (Verfall 13.09.2028).

Der Handel stellt eine barrierefreie, plangestützte Veräußerung dar und umfasst eine überschaubare Anzahl von Aktien im Vergleich zu Nateras über 100 Millionen ausstehenden Aktien, was auf eine begrenzte fundamentale Auswirkung auf die Kapitalstruktur des Unternehmens hindeutet. Dennoch beobachten Investoren Insider-Verkäufe oft als Stimmungsindikator, selbst wenn sie im Rahmen von 10b5-1-Plänen erfolgen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chapman Steven Leonard

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO AND PRESIDENT
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/01/2025 S 1,008(1) D $163.9964(2) 178,063 D
Common Stock 07/01/2025 S 500(1) D $165.834(3) 177,563 D
Common Stck 07/01/2025 S 3,187(1) D $167.1914(4) 174,376 D
Common Stock 07/01/2025 S 648(1) D $167.7685(5) 173,728 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.55 to $164.35 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.48 to $166.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.64 to $167.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.6750 to $167.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Vincent Fontanilla, Attorney-in-Fact 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many NTRA shares did Director Gail Marcus Boxer sell on July 1 2025?

She sold 4,299 shares of Natera common stock in two separate transactions.

What prices did the NTRA shares sell for?

Weighted-average sale prices were $167.0518 and $167.5554, with ranges detailed in the filing.

Were the sales made under a Rule 10b5-1 trading plan?

Yes. The plan was adopted on December 11 2024, satisfying Rule 10b5-1(c) requirements.

How many NTRA shares does the director own after the transactions?

Boxer holds 8,118 shares directly after the reported sales.

What option was exercised in the Form 4 filing?

A stock option for 4,299 shares with a $24.42 strike price, expiring 09/13/2028, was fully exercised.

Does this insider activity affect Natera’s share count or cause dilution?

No. The option was already granted; exercise and market sale do not change the company’s total outstanding shares.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

22.96B
131.58M
3.45%
93.67%
2.13%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN